8 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | — | -$21M | — | — | — | $5M | $1M |
| 2024 | $51M | -$34M | 19.5% | -6.1% | -$9M | — | $5M |
| 2023 | $94M | -$90000 | 20.6% | 0.5% | -$4M | — | $9M |
| 2022 | $70M | -$14M | 16.6% | -20.5% | -$12M | — | $13M |
| 2021 | $55M | -$39M | 11.8% | -69.6% | -$39M | $214000 | $11M |
| 2020 | $64M | -$30M | 23.8% | -45.7% | -$11M | $362000 | $22M |
| 2019 | $116M | -$26M | 29.7% | -19.3% | -$35M | $10M | $11M |
| 2018 | $136M | $1M | 35.4% | 4.0% | $3M | $14M | $13M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | — | $6M | — | — | — | $1M | $1M |
| Dec '25 | — | -$9M | — | — | — | $5M | $1M |
| Sep '25 | $16M | -$5M | 11.2% | -24.5% | — | $5M | $2M |
| Jun '25 | $11M | -$7M | 7.6% | -60.2% | — | $3M | $2M |
| Mar '25 | $17M | $458000 | 50.0% | -5.2% | — | $3M | $2M |
| Dec '24 | $15M | -$22M | -1.2% | 55.3% | -$5M | — | $5M |
| Sep '24 | $15M | -$3M | 28.2% | -15.8% | -$554000 | — | $9M |
| Jun '24 | $12M | -$7M | 25.8% | -56.2% | -$3M | — | $10M |
| Mar '24 | $9M | -$3M | 31.8% | -29.5% | -$198000 | — | $9M |
| Dec '23 | $13M | -$1M | 38.1% | -9.3% | -$363000 | — | $9M |
| Sep '23 | $28M | $527000 | 20.3% | 2.5% | -$305000 | — | $10M |
| Jun '23 | $27M | $509000 | 16.5% | 2.8% | — | — | $10M |
| Mar '23 | $26M | $227000 | 16.2% | 1.3% | — | — | $9M |
| Dec '22 | $24M | -$1M | 16.3% | -4.4% | -$2M | — | $13M |
| Sep '22 | $20M | -$2M | 16.2% | -9.4% | -$10M | $184000 | $15M |
| Jun '22 | $12M | -$4M | 23.8% | -35.3% | $762000 | — | $18M |
| Mar '22 | $13M | -$7M | 11.5% | -53.4% | -$612000 | $178000 | $11M |
| Dec '21 | $16M | -$12M | -3.1% | -73.7% | -$18M | $214000 | $11M |
| Sep '21 | $14M | -$11M | 12.4% | -74.2% | — | $251000 | $10M |
| Jun '21 | $12M | -$7M | 22.2% | -54.3% | — | $288000 | $7M |
How the market has priced SONM against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, DNA X, Inc.'s revenue has declined 15.2% per year. These are computed facts, not advice.
As of FY2025, DNA X, Inc. reported $5M of total debt against $1M of cash; operating income covered interest expense -5.7×.
In FY2025, gross margin was —, operating margin —, and net margin —.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.